NVHR believes that all people deserve access to treatment for hepatitis C. One of our top priorities is ensuring that public and private payers end all restrictions to treatment access.
On October 23, 2017, NVHR and the Center for Health Law and Policy Innovation of Harvard Law School released Hepatitis C: The State of Medicaid Access. This report details hepatitis C treatment prior authorization restrictions in all state Medicaid programs, including traditional fee-for-service as well as managed care. The report focuses on three of the most significant prior authorization restrictions to treatment: liver damage, sobriety, and prescriber limitations. It is the most comprehensive public listing of these restrictions to date.
We also released report cards for each state Medicaid program (including District of Columbia and Puerto Rico). These report cards provide a grade for each state based on their prior authorization restrictions and include recommendations for improving access for hepatitis C patients. Report cards are updated as states change their Medicaid policies.
In May 2018, NVHR submitted a sign-on letter in support of access to HCV treatment for Medicaid beneficiaries. We collected over 100 signatures. You can view it here.